Conflicts of interest and independent data analysis in industry-funded studies [1]

JAMA

Volumn 294, Issue 20, 2005, Pages 2575-2577

  Loew, Caroline J ^a   Molenberghs, Geert ^b   Imrey, Peter ^b   Drake, Christiana ^b   Fontanarosa, Phil B ^c   DeAngelis, Catherine D ^c  

^a Pharmaceutical Research and Manufacturers of America   (United States)

^b International Biometric Society   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; ROFECOXIB;

BIOMETRY; DATA ANALYSIS; DEFIBRILLATOR; DRUG INDUSTRY; DRUG MANUFACTURE; ETHICS; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL TOXICITY; HUMAN IMMUNODEFICIENCY VIRUS; LAW SUIT; LETTER; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONFLICT OF INTEREST; ECONOMICS; FINANCIAL MANAGEMENT; INDUSTRY; NOTE; PUBLISHING; PEER REVIEW;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; CLINICAL TRIALS; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; EDITORIAL POLICIES; INDUSTRY; RESEARCH SUPPORT; PEER REVIEW, RESEARCH;

EID: 28144433817     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.20.2575-a     Document Type: Letter

References (0)